Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FOLR1 expression
i
Other names:
FOLR1, Folate Receptor Alpha, Ovarian Tumor-Associated Antigen MOv18, Adult Folate-Binding Protein, Folate Receptor 1 (Adult), Folate Receptor, Adult, Folate Receptor 1, KB Cells FBP, FR-Alpha, FOLR, FBP, Folate Binding Protein, FRalpha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2348
Related biomarkers:
Expression
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
FOLR1 expression
Ovarian Cancer
FOLR1 expression
Ovarian Cancer
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Ovarian Cancer
FOLR1 expression
Ovarian Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Fallopian Tube Cancer
FOLR1 expression
Fallopian Tube Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Peritoneal Cancer
FOLR1 expression
Peritoneal Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Peritoneal Cancer
FOLR1 expression
Peritoneal Cancer
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Fallopian Tube Cancer
FOLR1 expression
Fallopian Tube Cancer
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
mirvetuximab soravtansine-gynx
Sensitive: A2 - Guideline
mirvetuximab soravtansine-gynx
Sensitive
:
A2
FOLR1 expression
Endometrial Cancer
FOLR1 expression
Endometrial Cancer
mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
mirvetuximab soravtansine-gynx
Sensitive
:
C3
mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
mirvetuximab soravtansine-gynx
Sensitive
:
C3
FOLR1 expression
Solid Tumor
FOLR1 expression
Solid Tumor
MORAb-202
Sensitive: C3 – Early Trials
MORAb-202
Sensitive
:
C3
MORAb-202
Sensitive: C3 – Early Trials
MORAb-202
Sensitive
:
C3
FOLR1 expression
Ovarian Cancer
FOLR1 expression
Ovarian Cancer
rucaparib + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
rucaparib + mirvetuximab soravtansine-gynx
Sensitive
:
C3
rucaparib + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
rucaparib + mirvetuximab soravtansine-gynx
Sensitive
:
C3
FOLR1 expression
Endometrial Cancer
FOLR1 expression
Endometrial Cancer
rucaparib + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
rucaparib + mirvetuximab soravtansine-gynx
Sensitive
:
C3
rucaparib + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
rucaparib + mirvetuximab soravtansine-gynx
Sensitive
:
C3
FOLR1 expression
Ovarian Cancer
FOLR1 expression
Ovarian Cancer
CT900
Sensitive: C3 – Early Trials
CT900
Sensitive
:
C3
CT900
Sensitive: C3 – Early Trials
CT900
Sensitive
:
C3
FOLR1 expression
Acute Myelogenous Leukemia
FOLR1 expression
Acute Myelogenous Leukemia
ELU001
Sensitive: D – Preclinical
ELU001
Sensitive
:
D
ELU001
Sensitive: D – Preclinical
ELU001
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login